Cargando…
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice
The tyrosine kinase human epidermal growth factor receptor 2 (HER2) gene is amplified in approximately 20% of human breast cancers and is associated with an aggressive clinical course and the early development of metastasis. Its crucial role in tumor growth and progression makes HER2 a prototypic on...
Autores principales: | Conti, Laura, Ruiu, Roberto, Barutello, Giuseppina, Macagno, Marco, Bandini, Silvio, Cavallo, Federica, Lanzardo, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065702/ https://www.ncbi.nlm.nih.gov/pubmed/25136593 http://dx.doi.org/10.1155/2014/534969 |
Ejemplares similares
-
A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model
por: Msaki, Aichi, et al.
Publicado: (2016) -
Multi-level model for the investigation of oncoantigen-driven vaccination effect
por: Cordero, Francesca, et al.
Publicado: (2013) -
Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice
por: Bandini, Silvio, et al.
Publicado: (2013) -
CSPG4: a prototype oncoantigen for translational immunotherapy studies
por: Rolih, Valeria, et al.
Publicado: (2017) -
MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment
por: Yuan, Hongyan, et al.
Publicado: (2018)